Immutep Limited logo

Immutep Limited

ASX:IMM.AX

Overview | Financials
Company Name Immutep Limited
Symbol IMM.AX
Currency AUD
Price 0.355
Market Cap 515,676,550
Dividend Yield 0%
52-week-range 0.23 - 0.485
Industry Biotechnology
Sector Healthcare
CEO Mr. Marc Voigt
Website https://www.immutep.com

An error occurred while fetching data.

About Immutep Limited

Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as a chemo-immunotherapy

Related Stocks

Capitol Health Limited logo

Capitol Health Limited

CAJ.AX

0.32 AUD

Trajan Group Holdings Limited logo

Trajan Group Holdings Limited

TRJ.AX

1.25 AUD

Starpharma Holdings Limited logo

Starpharma Holdings Limited

SPL.AX

0.098 AUD

Cogstate Limited logo

Cogstate Limited

CGS.AX

0.95 AUD

AFT Pharmaceuticals Limited logo

AFT Pharmaceuticals Limited

AFP.AX

3.2 AUD

Aroa Biosurgery Limited logo

Aroa Biosurgery Limited

ARX.AX

0.485 AUD

Race Oncology Limited logo

Race Oncology Limited

RAC.AX

1.7 AUD

Paradigm Biopharmaceuticals Limited logo

Paradigm Biopharmaceuticals Limited

PAR.AX

0.25 AUD

Pacific Smiles Group Limited logo

Pacific Smiles Group Limited

PSQ.AX

1.755 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD